Literature DB >> 23720089

New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography.

Hironori Tanaka1, Hiroko Iijima, Akiko Higashiura, Kazunori Yoh, Akio Ishii, Tomoyuki Takashima, Yoshiyuki Sakai, Nobuhiro Aizawa, Kazunari Iwata, Naoto Ikeda, Yoshinori Iwata, Hirayuki Enomoto, Masaki Saito, Hiroyasu Imanishi, Seiichi Hirota, Jiro Fujimoto, Shuhei Nishiguchi.   

Abstract

BACKGROUND: The ultrasonography contrast agent Sonazoid provides parenchyma-specific contrast imaging (Kupffer imaging) based on its accumulation in Kupffer cells. This agent also facilitates imaging of the fine vascular architecture in tumors through maximum intensity projection (MIP). We examined the clinical utility of the malignancy grading system for hepatocellular carcinoma (HCC) using a combination of 2 different contrast-enhanced ultrasonography images.
METHODS: We studied 121 histologically confirmed cases of HCC (well-differentiated, 45; moderately differentiated, 70; poorly differentiated, 6). The results of Kupffer imaging were classified as (1) iso-echoic pattern or (2) hypo-echoic pattern. The MIP patterns produced were classified into one of the following categories: fine, tumor vessels were not clearly visualized and only fine vessels were visualized; vascular, tumor vessels were visualized clearly; irregular, tumor vessels were thick and irregular. Based on the combined assessment of Kupffer imaging and the MIP pattern, the samples were classified into 4 grades: Grade 1 (iso-fine/vascular), Grade 2 (hypo-fine), Grade 3 (hypo-vascular), and Grade 4 (hypo-irregular).
RESULTS: The distribution of moderately and poorly differentiated HCCs was as follows: Grade 1, 4 % (1/24); Grade 2, 52 % (15/29); Grade 3, 85 % (44/52); and Grade 4, 100 % (16/16). The grading system also predicted portal vein invasion in 72 resected HCCs: Grade 1, 0 % (0/4); Grade 2, 13 % (1/8); Grade 3, 23 % (11/48); and Grade 4, 67 % (8/12).
CONCLUSIONS: This new malignant grading system is useful for estimation of histological differentiation and portal vein invasion of HCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23720089     DOI: 10.1007/s00535-013-0830-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  18 in total

1.  Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.

Authors:  Keiko Korenaga; Masaaki Korenaga; Matakazu Furukawa; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2009-04-23       Impact factor: 7.527

2.  Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography.

Authors:  Katsutoshi Sugimoto; Fuminori Moriyasu; Naohisa Kamiyama; Ryo Metoki; Masahiko Yamada; Yasuharu Imai; Hiroko Iijima
Journal:  Hepatol Res       Date:  2008-05-27       Impact factor: 4.288

3.  Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.

Authors:  M Hayashi; O Matsui; K Ueda; Y Kawamori; M Kadoya; J Yoshikawa; T Gabata; T Takashima; A Nonomura; Y Nakanuma
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

4.  Computed tomography and angiography of cavernous hemangiomas of the liver.

Authors:  C M Johnson; P F Sheedy; A W Stanson; D H Stephens; R R Hattery; M A Adson
Journal:  Radiology       Date:  1981-01       Impact factor: 11.105

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.

Authors:  S Tamura; T Kato; M Berho; E P Misiakos; C O'Brien; K R Reddy; J R Nery; G W Burke; E R Schiff; J Miller; A G Tzakis
Journal:  Arch Surg       Date:  2001-01

7.  Enhanced detection of blood flow in the normal canine prostate using an ultrasound contrast agent.

Authors:  E K Hagen; F Forsberg; A K Aksnes; D A Merton; J B Liu; A Tornes; D Johnson; B B Goldberg
Journal:  Invest Radiol       Date:  2000-02       Impact factor: 6.016

Review 8.  Complications of percutaneous abdominal fine-needle biopsy. Review.

Authors:  E H Smith
Journal:  Radiology       Date:  1991-01       Impact factor: 11.105

9.  Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model.

Authors:  Rira Watanabe; Manabu Matsumura; Chun-Jen Chen; Yuki Kaneda; Masanao Ishihara; Masayoshi Fujimaki
Journal:  Biol Pharm Bull       Date:  2003-09       Impact factor: 2.233

10.  Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images.

Authors:  Tatsuo Inoue; Masatoshi Kudo; Ryousuke Watai; Zhou Pei; Toshihiko Kawasaki; Yasunori Minami; Hobyung Chung; Toyokazu Fukunaga; Kazuo Awai; Osamu Maenishi
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 6.772

View more
  12 in total

1.  Proposal of objective morphological classification system for hepatocellular carcinoma using preoperative multiphase computed tomography.

Authors:  Hisashi Nakayama; Tadatoshi Takayama; Takao Okubo; Tokio Higaki; Yutaka Midorikawa; Masamichi Moriguchi; Akiyoshi Itoh
Journal:  J Gastroenterol       Date:  2013-11-16       Impact factor: 7.527

2.  Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Yuji Kaneoka; Atsuyuki Maeda; Seiji Okuda; Katsuhiko Otobe; Kenichi Takahashi
Journal:  Eur Radiol       Date:  2014-06-22       Impact factor: 5.315

3.  Low mechanical index contrast mode versus high mechanical index contrast mode: which is a more sensitive method for detecting Sonazoid microbubbles in the liver of normal subjects?

Authors:  Hiromi Nihonmatsu; Kazushi Numata; Hiroyuki Fukuda; Katsuaki Tanaka; Mari Ooba; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2015-11-14       Impact factor: 1.314

4.  Therapeutic evaluation of sorafenib for hepatocellular carcinoma using contrast-enhanced ultrasonography: Preliminary result.

Authors:  Kazue Shiozawa; Manabu Watanabe; Takashi Ikehara; Michio Kogame; Yoshinori Kikuchi; Yoshinori Igarashi; Yasukiyo Sumino
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

5.  Early hemodynamics of hepatocellular carcinoma using contrast-enhanced ultrasound with Sonazoid: focus on the pure arterial and early portal phases.

Authors:  Akiko Saito; Masakazu Yamamoto; Satoshi Katagiri; Shingo Yamashita; Masayuki Nakano; Toshio Morizane
Journal:  Glob Health Med       Date:  2020-10-31

Review 6.  Vascular evaluation using transabdominal ultrasound for gallbladder polyps.

Authors:  Haruo Miwa; Kazushi Numata; Kazuya Sugimori; Takashi Kaneko; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2020-03-03       Impact factor: 1.314

Review 7.  Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.

Authors:  Hitoshi Maruyama; Tadashi Sekimoto; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2015-12-22       Impact factor: 6.772

8.  Contrast-Enhanced Endoscopic Ultrasonography for Pancreatic Tumors.

Authors:  Yasunobu Yamashita; Jun Kato; Kazuki Ueda; Yasushi Nakamura; Yuki Kawaji; Hiroko Abe; Junya Nuta; Takashi Tamura; Masahiro Itonaga; Takeichi Yoshida; Hiroki Maeda; Takao Maekita; Mikitaka Iguchi; Hideyuki Tamai; Masao Ichinose
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

9.  Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.

Authors:  Hitomi Takada; Kaoru Tsuchiya; Yutaka Yasui; Natsuko Nakakuki; Nobuharu Tamaki; Shoko Suzuki; Hiroyuki Nakanishi; Jun Itakura; Yuka Takahashi; Masayuki Kurosaki; Yasuhiro Asahina; Nobuyuki Enomoto; Namiki Izumi
Journal:  Cancer Med       Date:  2016-10-17       Impact factor: 4.452

10.  Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma.

Authors:  Jinjin Yan; Xinzheng Yang; Lin Li; Pengtao Liu; Honghui Wu; Zhanao Liu; Qingyi Li; Guozhen Liao; Xinlong Wang
Journal:  Oncol Lett       Date:  2017-03-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.